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Overview
The overall focus of this review of diastolic function in heart 
failure is for the reader to have a better intuitive and concep-
tual grasp of how the heart works when it fills. Rather than 
describe the features of “diastolic function,” as is the current 
conventional tradition, in order to gain deeper understand-
ing it is more useful to view diastolic function as a problem 
to be solved! Once the basic problem of normal physiology of 
diastole has been mastered, it is nearly self-evident as to what 
the issues are in clinical heart failure and which physiologic 
mechanism and its hard-wired compensatory pathways one is 
confronted with. Extensive literature exists on the therapeutic 
options to be employed in every conceivable clinical setting 
where heart failure has been diagnosed; therefore, the focus 
here will be on physiology and pathophysiology, and, more 
importantly, on what diastolic function actually is, what it is 
not, and how to measure it.
Heart failure (HF), often called congestive heart failure 
(CHF), is commonly defined as a clinical diagnosis in a set-
ting of impaired pump function when the ejection fraction 
has been reduced and the heart muscle has weakened and is 
unable to pump sufficient volume of blood at the required 
pressure to maintain normal physiologic function. Actually, 
heart failure is more nuanced, and has been characterized by 
clinicians in terms of “left-sided heart failure”, where “left” 
refers to left ventricle (LV), “right-sided heart failure”, where 
“right” refers to the right ventricle (RV), “systolic heart fail-
ure”, implying overall inadequate pumping, and diastolic heart 
failure (DHF) or heart failure with preserved ejection fraction 
(HFpEF) where the ventricle(s) are unable to fully relax while 
they fill or fill incompletely at a sufficiently low pressure, to 
avoid pulmonary congestion in the time available for filling. It 
is relevant that, if patients are classified according to HF with 
reduced EF (HFrEF) or HFpEF, it is very likely that they 
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have multiple common comorbidities that are likely to affect 
both the management and the ultimate outcome. For example, 
pulmonary disease, diabetes, anemia, and obesity tend to be 
more prevalent in HFpEF than in HFrEF, but the prevalence 
of renal dysfunction and breathing disorders during sleep are 
similar between the groups. Furthermore, common cellular 
pathophysiologic mechanisms are likely to include inflamma-
tion and fibrosis at both the systemic and myocardial level.1
The general causal explanation for the clinical state of 
HF commonly involves coronary artery disease, ischemia and 
associated myocardial infarction, hypertension, diabetes, dis-
eases of the valves (valvulopathy), non-ischemic cardiomyo-
pathy, myocarditis, gradual adverse (rather than beneficial) 
remodeling of the chamber due to chronic arrhythmias (atrial 
fibrillation for example), alcoholism, obesity, and other less 
common ailments such as infiltrative myopathies (amyloido-
sis), hyperthyroidism, hypothyroidism, emphysema, hemo-
chromatosis, and congenital heart disease.
It immediately follows from the above description that the 
cellular and intracellular details of heart failure of any cause 
are biologically and conceptually complicated. Because of the 
electromechanic (conduction system → myocyte) mechanism, 
which Nature has evolved for the design of the myocardium, 
a design that allows for the presence of mechanoelectric feed-
back (stretch-activated ion channels), only selected aspects 
of how the entire system functions are understood at various 
dimensional scales (from molecular to organ level). As is char-
acteristic of biology, at the molecular and biochemical level 
all intracellular pathways [metabolism to generate adenosine 
triphosphate (ATP), intracellular component turnover (DNA, 
RNA, etc)] are coupled and interact in a myriad of known 
(and as yet unknown) ways and have evolved both feed-for-
ward control, feedback, and compensatory mechanisms. In 
spite of the obvious complexity of the system as evidenced 
by ∼105 sarcomeres (about 2 µm in length) per myocyte, with 
≈109 myocytes per LV, intracellular Ca++ ion concentration 
oscillates from micromolar to millimolar in tens of millisec-
onds, t-tubules form a three-dimensional Cartesian grid2 to 
ensure simultaneity of mechanical contraction (cross-bridge 
cycling) of a single cell via triggering of Ca++ channels and 
ryanodine receptors, the giant protein titin can have “stiff” 
or “soft” extensible region isoforms, myocytes are coupled 
mechanically by “rivets” (desmosomes) and electrically by con-
nexins (of various types), and fibroblasts (25% of LV volume, 
60%–70% by number, small 1 × 2 × 10 µm) exceed myocytes 
(75% by volume, but 30%–40% by cell number, large 20 µm 
diameter × 60 µm length) numerically in the myocardium and 
manage the extracellular matrix (ECM) in addition to having 
biochemical, structural, and electrical activity.3,4
basic Governing Physiologic Principles of How the 
Heart works when it Fills
In order to fully comprehend the elegance of diastolic function 
in normal physiology and how it is modified in heart failure, it 
is of value to review the basic principles that govern the mac-
roscopic function of the intact human heart.
The heart is a mechanical (muscle-powered) oscillator. 
To appreciate its design, it is useful to compare it to other 
components of human anatomy that are examples of muscle-
powered oscillatory function – for example, clenching the fist 
and then opening the fist to show the palm. This oscillatory 
action requires two muscle groups that reside in the fore-
arm: the extensors and the flexors. The action is voluntary, 
but when one group contracts, the other automatically relaxes, 
and vice versa. The duration, strength of closing, and opening 
the fist are under voluntary control. It is possible to close the 
fist and hold it in that form for an extended period. The four- 
chambered heart is also a muscle-powered oscillator. How-
ever, the LV is a single (woven) muscle group (shaped as a 
bowl), but it has no opposing muscle group. In spite of lacking 
an opposing muscle group (for precision, a technical correction 
here: in normal sinus rhythm atrial systole, the Doppler A- 
wave performs an opposing muscle group function by stretch-
ing the post-diastatic chamber. However, atrial contraction is 
not required for LV filling via the E-wave – as evidenced by 
rate-controlled atrial fibrillation), it decreases chamber size in 
systole when it contracts, and even when in isolation (such as 
in a Langendorf prep) it expands on its own (diastole) without 
another muscle group interacting with it, or when the source 
pressure for filling is zero (as in a freshly excised rat heart 
freely submersed in Krebs that swims around like a squid!). 
The method by which the chamber expands in early diastole 
presented a puzzle historically, because the muscle was known 
to contract (in systole), but no mechanism was known that 
made it “push” in diastole! This issue has been resolved, and 
there is general agreement that extracellular and intracellular 
elastic elements (essentially springs) are loaded in systole, 
which cause the chamber (myocytes, ECM, etc.) to return to its 
“equilibrium” configuration in diastole. These elastic elements 
include the ECM5 (primarily made of collagen and elastin), 
the intracellular giant protein titin,6 and the visceral pericar-
dium, which acts like a “shrink-wrap” and stores elastic energy 
in systole, contributing to the elastic recoil in diastole.7
The four-chambered heart is a (nearly perfect) constant-
volume pump. More precisely, what remains nearly constant 
volume during the cardiac cycle is the content of the pericar-
dial sac.8 The obvious consequence is that an A/P chest X-ray 
[by which heart size (cardiac silhouette) is often determined 
while holding one’s breath (to avoid diaphragmatic motion)] 
can be taken anytime during the cardiac cycle, without the 
need to gate the X-ray machine to the electrocardiogram 
(ECG)! The volume of the pericardial sac includes the blood 
pool in the atria and ventricles, the roots of the great ves-
sels, and the muscle. It is self-evident that the muscle mass 
remains constant during the cardiac cycle (except for a tiny 
correction due to cardiac lymphatics and coronary artery and 
vein caliber changes); therefore, the (near perfect) constancy 
of pericardial sack volume requires that the atrioventricular 
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volumes reciprocate, meaning, when the ventricles eject, the 
atria must fill.
The (near) constant volume, four-chamber physiology 
has been shown to apply to the left- and right-sided cham-
bers separately. This is not too surprising in light of the fact 
that the time-averaged spatial location of the midline of the 
interatrial septum and the LV septum remains essentially 
fixed in space during the cardiac cycle rather than shifting a 
large amount to the left or to the right. If the left heart was 
indeed a perfect constant-volume pump in systole and dias-
tole, atrial filling volume during ventricular systole (Doppler 
pulmonary vein S-wave, when the closed mitral valve plane 
is pulled downward by the contracting LV toward the apex, 
much like a piston in a syringe, and oxygenated blood is aspi-
rated by the descending closed mitral valve plane from the 
lung to fill the atrium) would equal the volume ejected by the 
LV. If this S-wave volume were to be equal to the LV systolic 
stroke volume, there would be no need for the existence of a 
pulmonary vein D-wave! Why? Because the aspirated atrial 
volume would enter the LV as the mitral annulus ascended. 
But the LV stroke volume is always more than the pulmo-
nary S-wave volume because of the slight epicardial displace-
ment during systole.9 Because the ejected LV stroke volume 
in systole is always greater than the simultaneously aspirated 
pulmonary vein S-wave volume entering atrium, the differ-
ence must be made up during the next Doppler E-wave as the 
(simultaneous) pulmonary vein D-wave. This explains why the 
four-chamber heart is – to within 95% – a constant-volume 
pump and it explains the conduit (blood flowing from lung 
to left heart during the E-wave) function of the left atrium!10 
The difference can be easily understood based on conservation 
of volume principles and visually appreciated as the “crescent 
effect” when the epicardial displacement of the LV during sys-
tole is compared to its location in diastole.
The difference between “volume pumping” and “pres-
sure pumping”. To appreciate these attributes, it is use-
ful to refer to the Wiggers Diagram for both the left and 
right ventricles, shown in the next column (http://starklab.slu.
edu/Physio/Circulation.htm).
It is self-evident that the right heart – the right ventricle 
in particular – is essentially a pure volume pump in both sys-
tole and diastole. This is because the pressure variation in the 
RV is about 15 mmHg – meaning that blood enters at about 
5–10 mmHg and leaves the RV at a pressure of 15–25 mmHg. 
In diastole, the RV pressure is lower than the right atrial 
pressure (RAP) during early rapid filling (tricuspid E-wave 
acceleration portion on Doppler) and the temporary diastolic 
atrioventricular gradient is about 3–5 mmHg. Essentially, the 
RV accepts blood at a low venous pressure and transports it 
to the lung with only a slight elevation of pressure, so that 
the mean PA pressure is 9–18 mmHg. The primary volume 
pumping attribute of the right heart is underscored by the 
observation that, due to the primarily longitudinal orienta-
tion of RV free wall muscle fibers, the oscillatory apex to base 
displacement of the tricuspid annulus during the cardiac cycle 
is greater (by at least 1 cm) than the apex to base oscillatory 
displacement of the mitral annulus.11 In contrast, for the left 
heart, the left atrium is always a volume pump, but the LV 
is a volume (suction) pump in diastole but a pressure–volume 
pump in systole. That is because the LV fills at a low (mean left 
atrial) pressure of about 10–15 mmHg, but empties at a high 
(mean) arterial pressure of .70 mmHg. In order for the LV 
to be a pressure pump in systole, additional circumferential 
weave is included in the mid-wall in addition to the helical 
fiber orientation that varies from endo to epi by 160º. Accord-
ingly, mitral annular excursion is less than tricuspid annular 
excursion.
In early diastole all LVs are mechanical suction pumps. 
The history of how the heart works when it fills has generated 
controversy, and, amazingly, some controversy remains to this 
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relating the physiology to the above-enumerated principles 
allows a definitive, causal-mechanism-based formalism by 
which diastolic function can be described, analyzed, taught, 
and (noninvasively) quantitated.
In 1930, in experiments in turtle hearts, Katz12 noted 
that during early diastole, after valve opening, the chamber 
continued to decrease its pressure while it increased its vol-
ume. In physiologic terms, dP/dt ,0, while simultaneously 
dV/dt .0, hence the chamber stiffness dP/dV ,0! But how 
should one interpret a negative chamber stiffness? Katz cor-
rectly concluded that the chamber was expanding (recoiling) 
faster than it could fill. He noted the same physiology (dP/
dV ,0) in the mammalian (dog) heart and correctly con-
cluded that the mammalian LV initiated filling by being a 
mechanical suction pump. The mechanism that explained 
this physiologic behavior was unknown to him. By 1985, 
the role of the heart as a suction pump5 was noted, with the 
elastic ECM (collagen, elastin) as the sole (recoiling spring) 
analog. Subsequently, intracellular spring elements (titin6) 
and extracellular attributes of the visceral pericardium7 have 
been shown to contribute to the mechanical recoiling of the 
LV wall responsible for recoil of the wall and filling of the 
chamber. The suction-pump physiology was often confused 
by the erroneous interpretation that the LV is a suction pump 
only when the left ventricular pressure (LVP) is below the 
atmospheric pressure (zero gauge pressure). This is mislead-
ing, since the source pressure for LV filling is (the mean) 
LAP rather than atmospheric pressure. Therefore, as long as 
the LV is able to decrease its pressure below LAP at mitral 
valve opening and for a bit thereafter, so that dP/dV ,0, all 
ventricles initiate filling by being mechanical suction pumps. 
This implies that all ventricles fill by the same physiologic 
and kinematic principles and that diastasis corresponds to 
the in vivo equilibrium volume of the chamber.13 What vary 
from one ventricle to another are the load and the parameters 
that govern the recoil/suction process (assuming a normal 
mitral valve).
diastolic function. The above basic principles immedi-
ately demonstrate that systole and diastole must be mechani-
cally coupled. In other words, ventricular contraction stores 
elastic energy in the tissue (as in compressing an equivalent 
spring), which powers the chamber wall recoil process. Implicit 
in this conceptual framework is that relaxation (sarcomere 
cross-bridge uncoupling) proceeds in a quantifiable manner. 
The key mechanistic advantage of the aforementioned frame-
work is that both chamber properties of stiffness (property of 
equivalent spring to generate recoil) and relaxation (rate and 
extent of cross-bridge uncoupling that modulates recoil pro-
cess) simultaneously determine global diastolic function. It is 
self-evident that diastolic function depends on the load (ie, 
the volume ejected affects end-systolic strain and the storage 
of elastic potential energy in tissue).
Common misconceptions remain about how the heart 
works when it fills. Diastolic function can be understood in a 
more intuitive way by recalling that the LV initiates filling by 
being a mechanical suction pump at, and for a little while after, 
mitral valve opening. That means that at mitral valve opening, 
blood does not get pushed into the ventricle by the atrium, 
but is instead mechanically aspirated by the ventricle.5,12,14 The 
answer to the question: “Where does the energy that drives 
suction come from?” is, systole. As the chamber contracts, 
overcomes the arterial load, and ejects, it simultaneously com-
presses the elastic elements. This stored elastic strain energy is 
released when the cardiac muscle relaxes, and the elastic ele-
ments generate the recoil of the ventricle until a fully relaxed 
equilibrium configuration of the chamber is achieved – usually 
during diastasis.
To fill effectively, the ventricle must become compliant 
during filling (not be too stiff), quickly relax the “cramp” that 
was the previous systole (effective cross-bridge uncoupling to 
achieve relaxation), and physically accommodate the aspirated 
blood volume. Thus, stiffness and relaxation are intrinsic ven-
tricular properties that determine how the tissue moves and 
are useful lumped parameters that determine and thereby 
quantitate diastolic function. It also follows that volumetric 
load (also termed preload) represents another extrinsic para-
meter that modulates the filling process.
conventional Measures of Global diastolic Function
The preferred method is echocardiography and, more specifi-
cally, Doppler measurement of transmitral flow. An excellent 
review is available15 Recommendations for LV DF assess-
ment have been published jointly by European Association of 
Echocardiography (EAE) and American Society of Echocar-
diography (ASE).16
Briefly, as a first approximation, E- and A-wave contours 
are simplified as having triangular shape, and triangle-based 
indexes, such as peak heights of the E- and A-waves and their 
ratio (Epeak, Apeak, Epeak/Apeak), the deceleration time and width 
of the E-wave (DT, Edur), and the velocity time integral (VTI) 
of the E- and A-waves (Fig. 1A), are routinely measured. The 


























Figure 1. (A) The current conventional triangle approximation to 
characterize E- and A-wave shapes. Using this approximation, Epeak, 
apeak, the duration of e-wave (edur), at, dt, epeak/apeak, and eVti/aVti are 
measured. (b) The often observed curvature change (inflection point) of 
the E-wave contour that is not a feature of the triangle approximation to 
e-wave shape. see text for details.
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current imaging technology allows the curvature of E-wave 
contours to be discerned (see Fig. 1B). Regrettably, the physi-
ologically important curvature features of the E-wave are usu-
ally disregarded. However, the benefit in understanding the 
physical and physiologic principles that govern E-wave shape 
and its curvature allows additional information to be extracted 
as detailed below [the parametrized diastolic filling (PDF) 
formalism].
The measurement of even smaller (ie, tissue) veloci-
ties permits measurement of the longitudinal mitral annular 
motion. The shapes of mitral annular Doppler tissue imaging 
(DTI) velocity contours are assumed (incorrectly) to be trian-
gles, with measurement restricted only of the peak E’. E’ had 
value for estimation of end-diastolic pressure.14 It is possible to 
extract physiologic information from the curvature and oscil-
lations of the E’-wave, as discussed below.
Additional capabilities include speckle tracking,17 which 
provides strain (change in length/per unit length) and strain 
rate (change in length/per unite length/per second) measure-
ments. Importantly, speckle tracking is necessarily a local or 
regional metric, and its utility in determining global diastolic 
function remains an area of investigation.
causality-based Measures of Global diastolic 
Function: the PdF Formalism
Using triangles to approximate E-wave contours has obvi-
ous limitations. Even less sensitive are metrics such as E/A or 
E-wave deceleration time.
By considering the heart as a suction pump and math-
ematically modeling its bulk motion, it is possible to gain 
deeper understanding into the physiologic determinants of the 
E-wave and its features such as its curvature.
The filling process can be modeled in analogy to the 
motion of a recoiling spring (a mechanical oscillator) that 
has an inertial load and is moving against a resistance.18 The 
model is the PDF formalism. More specifically, the formalism 
(kinematic model) is a way to analyze the Doppler E-wave and 
is derived from Newton’s laws of motion. It characterizes the 
E-wave in terms of a driving force (the atrioventricular 
pressure gradient), a damping/viscous force (relaxation or 
cross-bridge uncoupling that modulates recoil) resisting or 
opposing transmitral flow, and an inertial load due to tissue 
and blood.
The model involves solving the associated (differential) 
equation of motion, whose solution provides mitral flow veloc-
ity as a mathematical prediction of the solution to the equation 
of motion. Equivalently stated – all ventricles are mechanical 
suction pumps and fill by obeying the same law of motion. The 
features that differentiate diastolic function in one heart from 
another are the parameters that specify the motion, and they 
vary from heart to heart.
Each transmitral flow velocity (E-wave) contour is 
uniquely determined by three PDF model parameters: the 
initial displacement of the analogous spring xo (cm) [linearly 
related to E-wave VTI (ie, volumetric preload)],14 the stiffness 
of the “spring” denoted by parameter k (g/s2) that is linearly 
related to chamber stiffness (dP/dV),19 and a resistance para-
meter or chamber viscoelasticity index c (g/s), which accounts 
for energy losses that – by modulating recoil through relaxation 
– effectively act to oppose the filling process.14 In geometric 
terms, the spring constant k primarily determines the width 
of the E-wave. A high spring constant (stiff spring) generates 
a tall, narrow E-wave, as seen in the “constrictive-restrictive” 
pattern. The resistance/damping/relaxation parameter c is 
mainly responsible for modulating the deceleration portion or 
tail of the E-wave and is directly responsible for the inflection 
point (change in curvature from “cup-down” to “cup-up”) in 
the deceleration portion. An elevated value for the resistance/
damping parameter in general, relative to normal, gives rise to 
E-wave having the “delayed relaxation” pattern.
The three PDF model parameters (xo, c, and k) for each 
E-wave can be obtained through model-based image process-
ing (MBIP), detailed in Figure 2. Briefly, after the E-wave is 
selected, its maximum velocity envelope is identified and is fit 
numerically by the solution to the PDF equation of motion, 
yielding the three best fit PDF parameters (xo, c, k) and a 
measure of goodness of fit. The details of the method and 
instructions as to its use by anyone seeking to perform E-wave 
analysis have been detailed elsewhere.20
Diastolic function quantitation by analysis of E-wave 
using the PDF has shown that diabetes increases the resis-
















c = 14.8 ± 0.5/s
k = 110.8 ± 1.2/s2
x0= 16.5 ± 0.2 cm
MSE = 0.09 cm
Figure 2. Quantitation of diastolic function via the PDF formalism. As the sequence of panels shows, the raw echo (DICOM) image is frame-grabbed, 
the E-wave is cropped, and the maximum velocity envelope (MVE) is identified and fitted numerically by the solution to the PDF model, yielding the three 
unique best fit PDF parameters of load, relaxation and chamber stiffness (xo, c, k) and a measure of goodness of fit. See text for details.
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Importantly, these two studies showed that for hearts with 
normal left ventricular ejection fraction (LVEF), in contrast 
to the relaxation/viscosity parameter c, conventional E-wave 
indexes such as Epeak or DT were unable to differentiate 
between normal and diabetic subjects. A further insight 
provided by the approach is that, because energy must be 
lost during the filling process due to the resistance/relax-
ation (cross-bridge uncoupling that modulates recoil) term 
in the equation of motion, all ventricles fill to a diastatic 
volume that must be less than the maximum (lossless) ideal 
filling volume. An index that characterizes this efficiency 
of filling, the kinematic filling efficiency index (KFEI), has 
been shown to be lower in normal LVEF diabetic hearts 
compared to nondiabetic normal controls.23 Further-
more, the PDF parameter c has been shown to be linearly 
related to simultaneous chamber relaxation characterized 
by the (invasively determined) time-constant of isovolumic 
relaxation.24
doppler tissue Imaging
DTI has become routine in diastolic function assessment, 
including the ability to image the E’-wave and its subsequent 
multiple annular oscillations, which have been previously 
noted.25,26 Such oscillations may have been considered to be 
noise. Importantly, these annular oscillations obey the laws 
of oscillatory motion and therefore are amenable to quanti-
tation.27–29 The presence or absence of annular oscillations is 
often encountered in clinical imaging using DTI.
The ability to image longitudinal motion and radial 
motion to high precision has permitted the characterization 
of spatially distinct compensatory mechanisms in diastole. In 
other words, because maintenance of cardiac output via main-
tenance of stroke volume constitutes the prime directives for 
survival, it follows that impairment of longitudinal motion 
should be accompanied by compensation in radial motion in 
order to preserve stroke volume.
The information obtained from DTI holds great potential 
for diagnosis of diastolic relaxation abnormalities. The absence 
of mitral annulus oscillation (MAO) is a good predictor of 
relaxation-related diastolic dysfunction. In prior work,30 
we found that patient groups without MAO tend to have 
prolonged τ and isovolumic relaxation time (IVRT), lower 
Epeak/Apeak and E’-waves, and increased Epeak/E′.
solution of the Load-independent Index of diastolic 
Function Problem
An obvious problem in the quantitation of diastolic function 
relates to the load dependence of the conventional metrics 
proposed to date. Some correlations regarding only a limited 
dependence on load have been made regarding E′, but these 
are merely correlation, rather than causal-mechanism-based. 
The traditional (Epeak/Apeak, VTI, AT, DT) and newer echo-
derived indices (E/E′, strain, strain rate, Vp, etc) are known 
to be load-dependent. Hence, a load-independent index of 
diastolic function (LIIDF), though highly sought and desired, 
has not been available.
Because a LIIDF is not available, clinical practice has 
averaged measurements from multiple beats. Specifically, for 
Epeak, several consecutive E-waves are recorded, and then 
reported as the average Epeak. Thus DF information present in 
beat to beat, ie, load variation, is lost due to averaging.
The kinematic modeling approach to diastolic function 
characterization has allowed us to solve the LIIDF problem.31 
The key insight lies in analyzing not just one, but several 
E-waves, acquired at varying load states, and, rather than 
averaging and losing load-dependent information, making use 
of the variability of each E-wave in response to load. To deter-
mine the LIIDF, we compute the three PDF parameters: stiff-
ness (k), damping (c), and initial load parameters (xo), for each 
E-wave. In addition, Epeak is recorded. For each E-wave, the 
product of k and xo provides model-predicted maximum driv-
ing force, which is the analog of the peak instantaneous atrio-
ventricular pressure gradient. The product of each E-wave’s c 
and Epeak defines the maximum resistive force opposing filling. 
Thus, for each load-varying E-wave, we compute kxo and the 
associated cEpeak, and for each E-wave we plot a point in the 
kxo versus cEpeak coordinate system. The LIIDF is the slope, 
called M, of the linear regression between all (cEpeak, kxo) 
points, where each point is generated by a separate E-wave 
obtained under a different load.
In healthy volunteers undergoing tilt-table maneuvers, 
despite the dramatic visual E-wave shape variation, all associ-
ated (cEpeak, kxo) points remained colinear (R2 = 0.98), dem-
onstrating that the slope of the kxo versus cEpeak relation is 
independent of load. Furthermore, we found that, in subjects 
undergoing cardiac catheterization, the LIIDF was signifi-
cantly lower in subjects having diastolic dysfunction (elevated 
filling pressures .18 mmHg), compared to subjects with nor-
mal diastolic function. Thus, the LIIDF is easily determined 
from a series of load-varying E-waves; it is constant in the 
setting of load variation, and differentiates between normal 
versus diastolic dysfunction subjects. The practical utility 
and clinical power of the LIIDF resides in its application in 
sequential studies where each subject serves as his/her own 
control. Hence, whether therapy has resulted in “beneficial” or 
“adverse remodeling” of the chamber can be assessed in load-
independent terms. Furthermore, the LIIDF in and of itself 
can serve as a therapeutic target.
summary
In addressing the issue of diastolic function in heart failure, 
emphasis has been on viewing diastolic function as a problem 
to be solved, rather than correlating mere features of transmi-
tral waveforms with clinical features. By understanding that 
diastolic function is actually a measure of the suction pump 
attribute of the chamber, causally determined by chamber 
properties of stiffness, relaxation, and their response to load, 
it is possible to characterize diastolic function in accordance 
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with the laws of motion that apply to all hearts. Measure-
ment of diastolic function then becomes the act of analyzing 
E-waves (or E’-waves) via the PDF formalism and determin-
ing the model-derived indexes of stiffness, relaxation, and 
load. These metrics allow sensitive and specific differentiation 
of diastolic dysfunction states relative to controls32 and pro-
vide further opportunity to assess chamber remodeling via the 
LIIDF. The method is ideally suited to more fully characterize 
the physiology of HFpEF33,34 using echocardiography.
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